823 related articles for article (PubMed ID: 12699449)
1. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone (GH) secretion and pituitary size in children with short stature. Efficacy of GH therapy in GH-deficient children, depending on the pituitary size.
Hilczer M; Szalecki M; Smyczynska J; Stawerska R; Kaniewska D; Lewinski A
Neuro Endocrinol Lett; 2005 Oct; 26(5):447-52. PubMed ID: 16264418
[TBL] [Abstract][Full Text] [Related]
3. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
Korpal-Szczyrska M; Dorant B; Kamińska H; Birkholz D; Niedźwiecki M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
[TBL] [Abstract][Full Text] [Related]
5. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
[TBL] [Abstract][Full Text] [Related]
6. Role of magnetic resonance imaging in the diagnosis and prognosis of growth hormone deficiency.
Bozzola M; Adamsbaum C; Biscaldi I; Zecca M; Cisternino M; Genovese E; Richard I; Kalifa G; Chaussain JL
Clin Endocrinol (Oxf); 1996 Jul; 45(1):21-6. PubMed ID: 8796134
[TBL] [Abstract][Full Text] [Related]
7. Final height and growth hormone secretion after completion of growth hormone therapy in patients with idiopathic growth hormone deficiency and with abnormalities of the hypothalamic-pituitary region.
Hilczer M; Smyczynska J; Stawerska R; Lewinski A
Neuro Endocrinol Lett; 2005 Feb; 26(1):19-24. PubMed ID: 15726014
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
[TBL] [Abstract][Full Text] [Related]
9. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
Ranke MB; Guilbaud O
Acta Paediatr Scand Suppl; 1991; 379():109-15; discussion 116. PubMed ID: 1815451
[TBL] [Abstract][Full Text] [Related]
10. Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency.
Loche S; Bizzarri C; Maghnie M; Faedda A; Tzialla C; Autelli M; Casini MR; Cappa M
J Pediatr; 2002 Apr; 140(4):445-9. PubMed ID: 12006959
[TBL] [Abstract][Full Text] [Related]
11. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
Seminara S; Stagi S; Candura L; Scrivano M; Lenzi L; Nanni L; Pagliai F; Chiarelli F
Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
[TBL] [Abstract][Full Text] [Related]
13. Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings.
Coutant R; Rouleau S; Despert F; Magontier N; Loisel D; Limal JM
J Clin Endocrinol Metab; 2001 Oct; 86(10):4649-54. PubMed ID: 11600520
[TBL] [Abstract][Full Text] [Related]
14. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
[TBL] [Abstract][Full Text] [Related]
15. Optic nerve size evaluated by magnetic resonance imaging in children with optic nerve hypoplasia, multiple pituitary hormone deficiency, isolated growth hormone deficiency, and idiopathic short stature.
Birkebaek NH; Patel L; Wright NB; Grigg JR; Sinha S; Hall CM; Price DA; Lloyd IC; Clayton PE
J Pediatr; 2004 Oct; 145(4):536-41. PubMed ID: 15480381
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
Moore WV; Dana K; Frane J; Lippe B
Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
[TBL] [Abstract][Full Text] [Related]
17. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
18. The response to treatment with pituitary growth hormone: the New Zealand experience.
Livesey JH; Cuneo RC; Donald RA; Harris RG; Ibberston HK; Costello JM; Holdaway IM; Gluckman PD; Fraser TR; Chapman GE
N Z Med J; 1989 Aug; 102(873):399-402. PubMed ID: 2761875
[TBL] [Abstract][Full Text] [Related]
19. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term.
de Zegher F; Hokken-Koelega A
Pediatrics; 2005 Apr; 115(4):e458-62. PubMed ID: 15805349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
